Astex Pharmaceuticals, Inc. (ASTX) Posts Q4 EPS of 5c; Lowers FY13 Outlook
Tweet Send to a Friend
Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) reported Q4 EPS of $0.05, versus a break event ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
